Wednesday, 29 October 2014
The Union is happy to invite all registered delegates and accompanying persons to a Welcome Reception.
Time: 19:00 - 20:30 Room: Banquet Hall
Workshops are complimentary. As spaces are limited, delegates must pre-register for the Workshop they would like to attend.
Workshops will take place on Wednesday, 29 October 2014, in parallel to other Workshops and Post-graduate Courses; delegates will be able to attend only one Workshop.
It is not mandatory to register for the whole conference to attend a Post-graduate Course; delegates are able to register for one Post-graduate Course only.
The registration fee to attend a Post-graduate Course is 100 €.
Post-graduate Courses will take place on Wednesday, 29 October 2014, in parallel to other Post-graduate Courses and Workshops; delegates can only attend one Post-graduate Course.
|01. Project Management||Tuberculosis||09:00 - 17:00||127|
|02. An introduction to tuberculosis modelling (TB modelling and analysis consortium)||Tuberculosis||09:00 - 17:00||128|
|03. Innovative and effective training for community workers||Nurses and Allied Professionals||09:00 - 17:00||129|
|04. An introduction to pragmatic randomised controlled trials in low- and middle- income countries||Tobacco||09:00 - 17:00||130|
|05. Communicating effectively: in person and on paper||Tuberculosis||09:00 - 17:00||131|
|06. Optimising current and novel TB combination therapy based on PK/PD science and biological variability||Tuberculosis||09:00 - 12:30||132|
|07. Update on clinical and programmatic management of MDR-TB and XDR-TB||Tuberculosis||09:00 - 17:00||133/134|
The Inaugural Session followed by the Award Ceremony will be held on Wednesday, 29 October 2014 from 17:30 to 19:00 in the Auditorium.
Wednesday, 29 October 2014
Time: 17:30-19:00 Room: Auditorium
Sir John Crofton Memorial Lecture: "The role of legislative advocacy for TB and other lung health conditions"
Speaker: Rt Hon. Nick Herbert, MP and co-chair of the All Party Parliamentary Group on Global TB (UK)
"Old disease, new ambitions: Zero TB deaths in our lifetime"
Speaker: Dr Aaron Motsoaledi, Minister of Health for South Africa & Chair of the Stop TB Partnership Board
"The role of communities in the management and care of persons living with tuberculosis, HIV and other lung health issues"
Speaker: Ria Grant
Chairs: E Jane Carter (USA), Rajita Bhavaraju (USA)
Nick Herbert (UK)
Nick Herbert is the UK Member of Parliament for Arundel and South Downs. He was first elected in 1997 as the Conservative Parliamentary member from Berwick Upon Tweed, one of the most rural seats in England. Herbert is passionate about defending rural communities and played a leading role in what is now the Countryside Alliance. He also directed the highly regarded independent think tank, Reform.
In Parliament, he has held the positions of Shadow Minister for Police Reform, Shadow Secretary of State for Justice and Shadow Secretary of State for Environment, Food and Rural Affairs. Herbert also served as Minister of State for Policing and Criminal Justice from 2010 to 2012.
Since becoming an MP, Herbert has worked closely with the development charity Results on the global problem of tuberculosis. In 2006 he helped to form, and was elected co-chairman of, the All Party Parliamentary Group on Global TB. He returned as co-chairman in 2013.
Aaron Motsoaledi (South Africa)
Dr Aaron Motsoaledi, Minister of Health for South Africa & Chair of the Stop TB Partnership Board
Aaron Motsoaledi has been South Africa's Minister of Health since 2009. Dr Motsoaledi became politically aware at a young age. He was in high school at the time of the Soweto uprisings of 1976, and he was active in the liberation struggle as a college and medical student. In 1983 he was instrumental in mobilising students at the University of Natal to form the United Democratic Front. As a medical intern, he was involved in the African National Congress’s armed wing, and in 1980 he was elected chair of the Northern Transvaal Reception Committee. He became deputy chair of the ANC Northern Transvaal (now Limpopo) region when it was launched in 1990 and served on the Limpopo Provincial Executive Committee of the ANC for 19 years. He was then elected to the ANC National Executive Committee, where he serves today.
Dr Motsoaledi holds bachelors’ degrees in medicine and surgery from the University of KwaZulu-Natal and is a member of the Ministerial Advisory Committee for the NHI and South African National AIDS Council.
Ria Grant (South Africa)
Ria Grant is both Senior Advisor for South Africa’s TB/HIV Care Association and a member of the Developing Country NGO Delegation to the Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund).
As a long-time TB nurse in the Cape Town area, Mrs Grant became aware of how crucial a TB patient’s social environment is to both causing and curing the disease. She then became a caseworker for TB Care – now the TB/HIV Care Association – working closely with patients to address their clinical, material and psychosocial needs. She was appointed Director of TB/HIV Care Association, and since her retirement in 2009, continues as Senior Advisor.
Mrs Grant has also served as African Regional Communications Focal Point and Lead Communications Focal Point for the Developing Country NGO Delegation to The Global Fund, among other commitments. She has presented papers on TB/HIV Care's work internationally to communicate the importance of its mission.
Union Administrative Meetings
Communications, Membership & Fundraising Committee Meeting (CMFC)
IJTLD Board Meeting
Monday, 27 October 2014 - Wednesday, 29 October 2014
J2J PROGRAMME ROOM (Closed meeting)
The National Press Foundation and The Union are offering the 6th annual Journalist-to-Journalist (J2J) training on lung health issues at the World Conference. The training runs from 27-29 November, after which the journalists participate in the conference and post news stories from the venue. The training is designed for working journalists who want to increase their knowledge and skills they need to develop informed stories on lung health and related issues, such as the social, political and public health impact of lung disease. Sessions also cover the latest research, solutions and innovations that are in the pipeline.
Coordinators: Bob Meyers, Linda Streitfeld, National Press Foundation (USA); Paul Jensen, Katia Yezli, The Union
Wednesday, 29 October 2014
NEW FUNDING MODEL OF THE GLOBAL FUND (Meeting open to all delegates)
World Health Organisation GTB/TSC/TBTEAM
Time: 9:00 - 17:00
GF New Funding Model – Concept note development and technical support from TB partners: what support was provided, what worked well, what were the challenges and what can be done better, lessons learnt.
Coordinator: Malgosia Grzemska (Switzerland)
ANNUAL MEETING OF THE STOP TB PARTNERSHIP NEW DIAGNOSTICS WORKING GROUP
(Meeting open to all delegates)
“How can countries effectively use genotypic methods for managing MDR-TB?”
Time: 9:00 - 12:30
In this meeting we will review activities by the New Diagnostics Working Group as a coordination and communication platform to enable effective collaboration of stakeholders for accelerating progress in TB diagnostic research and development. We will more particularly report outcomes of recent meetings that the NDWG convened with partners to facilitate sharing and integration of sequencing data and to build consensus on high-priority Target Product Profiles. The session will also present progress in biomarker research for development of paediatric TB diagnostics, as well as latest study results on new technologies for multiplex drug susceptibility testing and for improved detection of TB at point-of-care and microscopy centre levels.
In the second part of the session a panel of clinical and laboratory experts will explore the state of genotypic and phenotypic testing in the context of low- and middle-income countries with a high burden of MDR-TB. While the knowledge correlating phenotypic and genotypic methods is rapidly evolving and promises to transform detection of drug resistance, the evidence to recommend genotypic methods as a replacement for phenotypic drug susceptibility testing is not yet available. The session will provide perspectives for considering genotyping approaches as the only feasible solution for high-burden countries which don’t have sufficient capacity for phenotypic testing. The panel will also discuss the challenges related to scaling-up genotypic methods into national guidance for treatment and management of MDR-TB in the low income setting.
Coordinators: John Ridderhof, CDC, NDWG Core Group, and Alessandra Varga, FIND, NDWG Secretariat
Chairs: Catharina Boehme, FIND, and Daniela Cirillo, San Raffaele Scientific Institute, NDWG Co-Chairs
FIND SYMPOSIUM (Meeting open to all delegates)
“Partnerships driving innovative diagnostic solutions in support of TB elimination”
Time: 13:30 - 17:00
The first part of the symposium will provide an update on the TB diagnostics pipeline. Presentations will highlight how FIND and partners are addressing diverse diagnostic challenges to support the 2020 Global targets for TB prevention, care and control. Speakers will report recent results of studies on promising technologies for case detection at point-of-care level for all populations, including children and people living with HIV, as well as on molecular solutions for improved identification of resistance to first- and second-line drugs.
In the second part of the session, a panel discussion on the theme of “Connected diagnostics: opportunities in overcoming bottlenecks in delivery” will follow an overview of current e-health efforts in diagnostics. The panel of international experts will include representatives of the public health sector and non-governmental organizations that are leading pioneer projects applying mobile and information technologies to healthcare in low- and middle-income countries, as well as companies providing solutions in this area. Panelists will discuss the potential of connectivity for improving TB diagnosis to effectively and affordably reach the estimated three million people that every year fail to access quality care.
Coordinator: Alessandra Varga, FIND (Switzerland),
Chair: Dr. Catharina Boehme, Chief Executive Officer, FIND, (Switzerland)
There will be a Scientific and Technical Exhibition during the conference showcasing a variety of companies, agencies, non-governmental organisations (NGOs), health organisations and manufacturers of materials and equipment.